Apellis Pharmaceuticals Inc. (APLS) Fell -5.81% or -1.45 To Price $23.49 On Friday


Apellis Pharmaceuticals Inc. (APLS) fell -5.81% or -1.45 to $23.49. It is nearly 100229 shares traded, which is 52.36% compare to the average total volume 191436. The market cap of APLS is $1.18 billion. The year to date change is 20.02%. The 52 week price range is from $12.45 to $25.33. Price of APLS have changed 21.48% during last week. It have changed 78.14% over last month, 77.76% over last 3 months, 77.76% over last 6 months and 77.76% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for APLS is 15.41. It is -34.40% below current price. The 200-day Moving Averages for APLS is 15.41. It is -34.40% below current price. The 52-week High is 25.33. It is 7.83% from the current price. The 52-week Low is 12.45. It is -47.00% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of APLS is 2.25 on 2017-12-15. Short % to float is 0.95%. There are some statistics of APLS. It is has market cap $1.18 billion. The share outstanding is 50.33 million. The average volume is 191436. The percent of top 15 Institution holding is 4.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of APLS is 39.53%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of APLS is -205.68%.


Tags:

Share this post